These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22581733)

  • 1. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations.
    Tamita K; Katayama M; Takagi T; Yamamuro A; Kaji S; Yoshikawa J; Furukawa Y
    Heart; 2012 Jun; 98(11):848-54. PubMed ID: 22581733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
    David LA; Grosu AA
    Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
    Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
    Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognosis is related to mid-term changes of glucometabolic status in patients with acute myocardial infarction treated invasively.
    Francuz P; Podolecki T; Przybylska-Siedlecka K; Kalarus Z; Kowalczyk J
    Kardiol Pol; 2017; 75(2):117-125. PubMed ID: 27714713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis.
    Laichuthai N; Abdul-Ghani M; Kosiborod M; Parksook WW; Kerr SJ; DeFronzo RA
    Diabetes Care; 2020 Aug; 43(8):1958-1966. PubMed ID: 32669411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction.
    Tamita K; Katayama M; Takagi T; Akasaka T; Yamamuro A; Kaji S; Morioka S; Kihara Y
    Circ J; 2007 Jun; 71(6):834-41. PubMed ID: 17526977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly detected abnormal glucose regulation and long-term prognosis after acute myocardial infarction: Comparison of an oral glucose tolerance test and glycosylated haemoglobin A1c.
    Pararajasingam G; Høfsten DE; Løgstrup BB; Egstrup M; Henriksen FL; Hangaard J; Egstrup K
    Int J Cardiol; 2016 Jul; 214():310-5. PubMed ID: 27085117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
    George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J
    PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study.
    Kitada S; Otsuka Y; Kokubu N; Kasahara Y; Kataoka Y; Noguchi T; Goto Y; Kimura G; Nonogi H
    Cardiovasc Diabetol; 2010 Nov; 9():75. PubMed ID: 21070650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively.
    Mazurek M; Kowalczyk J; Lenarczyk R; Zielinska T; Sedkowska A; Pruszkowska-Skrzep P; Swiatkowski A; Sredniawa B; Kowalski O; Polonski L; Strojek K; Kalarus Z
    Cardiovasc Diabetol; 2012 Jun; 11():78. PubMed ID: 22741568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated one hour with normal fasting and 2 h plasma glucose helps to identify those at risk for development of Type2 Diabetes-11 years observational study from south India.
    Kumpatla S; Parveen R; Stanson S; Viswanathan V
    Diabetes Metab Syndr; 2019; 13(4):2733-2737. PubMed ID: 31405701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study.
    Lee G; Kim SM; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Park SM
    Cardiovasc Diabetol; 2018 Apr; 17(1):51. PubMed ID: 29626936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.
    Wallander M; Söderberg S; Norhammar A
    Diabet Med; 2008 Aug; 25(8):949-55. PubMed ID: 18959608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
    Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
    Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke.
    Tanaka R; Ueno Y; Miyamoto N; Yamashiro K; Tanaka Y; Shimura H; Hattori N; Urabe T
    J Neurol Sci; 2013 Sep; 332(1-2):45-50. PubMed ID: 23810779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes.
    Tenerz A; Norhammar A; Silveira A; Hamsten A; Nilsson G; Rydén L; Malmberg K
    Diabetes Care; 2003 Oct; 26(10):2770-6. PubMed ID: 14514578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly diagnosed abnormal glucose tolerance determines post-MI prognosis in patients with hospital related hyperglycaemia but without known diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    J Diabetes Complications; 2020 Apr; 34(4):107518. PubMed ID: 31924528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    Acta Diabetol; 2018 May; 55(5):449-458. PubMed ID: 29450734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.